Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.06434 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.29809 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.99506 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.17148 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.30344 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.66964 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.12791 | 77 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.80063 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.10498 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.0681 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.13994 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.21036 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.41471 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.03275 | 76 |